Histopathological and molecular characteristics of IDH-wildtype glioblastoma without contrast enhancement: Implications for clinical outcomes.
Saved in:
| Title: | Histopathological and molecular characteristics of IDH-wildtype glioblastoma without contrast enhancement: Implications for clinical outcomes. |
|---|---|
| Authors: | Foltyn-Dumitru M; Division for Computational Radiology & Clinical AI, Bonn University Hospital, Bonn, Germany.; Department of Neuroradiology, Bonn University Hospital, Bonn, Germany.; Division for Computational Neuroimaging, Heidelberg University Hospital, Heidelberg, Germany.; Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany., Banan R; Department of Neuropathology, Heidelberg University Hospital, Heidelberg, Germany., Schell M; Division for Computational Neuroimaging, Heidelberg University Hospital, Heidelberg, Germany.; Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany., Mahmutoglu MA; Department of Radiology and Nuclear Medicine, Diagnostic and Interventional Neuroradiology, University Hospital Basel, University of Basel, Basel, Switzerland.; Division for Computational Neuroimaging, Heidelberg University Hospital, Heidelberg, Germany.; Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany., Kessler T; Clinical Cooperation Unit Neurooncology, German Cancer Research Center (DKFZ, Heidelberg, Germany.; Department of Neurology and Neurooncology Program, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany., Wick W; Clinical Cooperation Unit Neurooncology, German Cancer Research Center (DKFZ, Heidelberg, Germany.; Department of Neurology and Neurooncology Program, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany., Brugnara G; Division for Medical Image Computing (MIC), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Division for Computational Radiology & Clinical AI, Bonn University Hospital, Bonn, Germany.; Department of Neuroradiology, Bonn University Hospital, Bonn, Germany.; Division for Computational Neuroimaging, Heidelberg University Hospital, Heidelberg, Germany.; Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany., Bendszus M; Division for Computational Neuroimaging, Heidelberg University Hospital, Heidelberg, Germany.; Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany., Sahm F; Clinical Cooperation Unit Neuropathology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Neuropathology, Heidelberg University Hospital, Heidelberg, Germany., Vollmuth P; Division for Medical Image Computing (MIC), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Division for Computational Radiology & Clinical AI, Bonn University Hospital, Bonn, Germany.; Department of Neuroradiology, Bonn University Hospital, Bonn, Germany.; Division for Computational Neuroimaging, Heidelberg University Hospital, Heidelberg, Germany.; Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany. |
| Source: | Neuro-oncology [Neuro Oncol] 2025 Sep 08; Vol. 27 (7), pp. 1878-1887. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1523-5866 |
|---|---|
| DOI: | 10.1093/neuonc/noaf070 |
